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Embryonic development of the liver has been studied intensely, yielding insights that impact diverse areas of
developmental and cell biology. Understanding the fundamentalmechanisms that control hepatogenesis has
also laid the basis for the rational differentiation of stem cells into cells that display many hepatic functions.
Here, we review the basic molecular mechanisms that control the formation of the liver as an organ.The liver is the largest gland in the body exhibiting both endo-
crine and exocrine properties. Endocrine functions include the
secretion of several hormones such as Insulin-like growth
factors, Angiotensinogen, and Thrombopoietin, while the major
exocrine secretion is in the form of bile. The liver is also essential
for glycogen storage, drug detoxification, control of metabolism,
regulation of cholesterol synthesis and transport, urea metabo-
lism, and secretion of an extensive array of plasma proteins
including Albumin and Apolipoproteins. Since the liver is such
an important regulator of normal physiological processes, liver
disease, such as hepatic fibrosis, cirrhosis and hepatitis, and
hepatocellular carcinoma, results in high rates of morbidity and
mortality, so much so that liver disease is the fourth leading
cause of death among middle-aged adults in the United States.
The high economical and health burden resulting from liver
disease has prompted a call to increase understanding of the
basic developmental mechanisms that control liver cell differen-
tiation and function (Action Plan for Liver Disease Research:
http://www2.niddk.nih.gov/).
The advances made over the last two decades of hepatic
research have been substantial. The fact that liver mass
accounts for between 2%–5% of body weight and because
the majority of cells within the liver are hepatocytes made the
liver highly accessible for the purification of proteins using tradi-
tional biochemical procedures. This included the isolation of
transcription factors, growth factors, signaling molecules, and
hormones that were challenging to identify in other organs and
tissues. During the latter half of the 20th century, facilitated by
the explosion of molecular biology, our depth of understanding
of control of gene expression within the context of the hepato-
cyte was arguably better understood than within in any other
cell type. Many technologies that became key to the investiga-
tion of cell function in general, such as the production of cDNA
libraries, electromobility shift assays to identify DNA binding
proteins, and in vivo DNA footprinting to identify the occupancy
of transcription factors within promoters, were first established in
the liver. In addition to facilitating rapid advances in the study of
gene expression, the ability of the liver to regenerate in response
to insult also allowed identification of the mechanisms that regu-
late mammalian cell proliferation, cell cycle, and DNA repair
in vivo. Most of these advances, whether it be in understanding
control of gene expression or cell proliferation, describe funda-
mental mechanisms that are applicable to all aspects of biology.Architecture of the Liver
To understand the molecular basis of hepatogenesis it is first
necessary to first consider the structure of the adult liver. In
contrast to most complex organs, histological sections through
the liver reveal a rather homogeneous landscape of hepatocytes
periodically infiltrated with vascular tissue and bile ducts
(Figure 1A). This somewhat bland histological appearance
masks an extremely complex and under appreciated tissue
architecture that is crucial for normal hepatic function (Figures
1B and C). The basic architectural unit of the liver is the liver
lobule. The lobule consists of plates of hepatocytes lined by sinu-
soidal capillaries that radiate toward a central efferent vein. Liver
lobules are roughly hexagonal with each of six corners demar-
cated by the presence of a portal triad of vessels consisting of
a portal vein, bile duct, and hepatic artery (Figure 1B). Both the
portal vein and hepatic artery supply blood to the lobule, which
flows through a network of sinusoidal capillaries before leaving
the lobule through the central vein. Although hepatocytes are
the major parenchymal cell type of the liver and account for
78% of liver volume (Blouin et al., 1977), they function in concert
with cholangiocytes (biliary epithelial cells), endothelial cells,
sinusoidal endothelial cells, Kupffer cells (resident liver macro-
phages), pit cells (natural killer cells), and hepatic stellate cells
(see Table 1).
The hepatocytes, which are polarized epithelial cells, are ar-
ranged as cords that are one cell thick in mammals. The basolat-
eral surfaces of the hepatocyte face fenestrated sinusoidal
endothelial cells, which facilitates the transfer of endocrine
secretions from the hepatocytes into the blood stream
(Figure 1C). Tight junctions formed between neighboring hepato-
cytes generate a canaliculus that surrounds each hepatocyte
and is responsible for collection of bile acids and bile salts that
are transported across the hepatocyte’s apical surface. Bile
collected by the canaliculi is carried to the bile ducts within the
portal triad and subsequently transported for storage in the gall
bladder. As shown in Figure 1C, the complex arrangement
between the polarized hepatocytes with the capillaries and chol-
angiocytes underlies both endocrine and exocrine functions of
the liver. The challenge facing developmental biologists is to
understand the molecular events that lead to the generation of
each cell type within the liver and to determine how the cells
arrange to form the three-dimensional architecture that is so
crucial for hepatic function.Developmental Cell 18, February 16, 2010 ª2010 Elsevier Inc. 175
Figure 1. Architecture of the Liver
(A) Hematoxylin-stained section through a human liver showing homogenous
distribution of cells.
(B) Illustration showing overall structure of a portion of a liver lobule.
(C) Higher resolution of the relationship between key cellular compartments of
the liver.
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Signaling Pathways Controlling Onset of Liver
Parenchymal Cell Differentiation
The parenchymal cells of the liver derive from the anterior portion
of the definitive endoderm (Figure 2), which itself is established in
the embryo during gastrulation (Le Douarin, 1975). Labeling of176 Developmental Cell 18, February 16, 2010 ª2010 Elsevier Inc.anterior endoderm in mouse embryos with vital dyes has re-
vealed the presence of three distinct domains of hepatic progen-
itor cells that are located in the medial and bilateral regions of the
foregut (Tremblay and Zaret, 2005). As the foregut closes, the
progenitor cells within these regions converge to lie adjacent
to the developing heart and in close apposition to regions of
lateral plate mesoderm that will ultimately generate the mesothe-
lial cells of the proepicardium and septum transversum. Cocul-
ture studies using either chick or mouse embryos demonstrated
that the developing cardiac mesoderm plays a crucial instructive
role during the induction of hepatic cell fate (when the embryo
has generated roughly 7–8 pairs of somites; LeDouarin, 1964;
Houssaint, 1980; Gualdi et al., 1996). Using modern molecular
techniques these inductive signals were found to be members
of the fibroblast growth factor family, since FGF1 and FGF2
could substitute for cardiac tissue in inducing the onset of
Albumin expression, a characteristic marker of hepatic cell
fate, in explants of mouse anterior endoderm (Gualdi et al.,
1996; Jung et al., 1999). Moreover, FGF-mediated specification
of hepatic cell fate is concentration dependent and this appears
to be controlled by the position of the endoderm relative to the
heart, which is the major source of hepatogenic FGF (Deutsch
et al., 2001; Serls et al., 2005).
The induction of hepatic gene expression by FGF is controlled
specifically through activation of the MAPK pathway and is inde-
pendent of PI3K signaling (Calmont et al., 2006). Several FGFs
including Fgf1, Fgf2, Fgf8, and Fgf10 are expressed in the
cardiac mesoderm during the onset of hepatogenesis, and
studies of knockout mice suggest that functional redundancy
exists between these factors in controlling liver development
(Miller et al., 2000). Nevertheless, the requirement for FGF
signaling in controlling the onset of liver development is evolu-
tionarily conserved, with FGFs displaying hepatogenic proper-
ties in Xenopus, chick, and Zebrafish embryos (Chen et al.,
2003; Shin et al., 2007; Zhang et al., 2004).
Coculture studies using either chick-quail grafts or mouse
embryos uncovered a mesenchymal cue necessary for early
hepatic development (LeDouarin, 1968; Houssaint, 1980). A
cluster of mesenchymal cells that give rise to the mesothelium
of the peritoneal cavity, the cardiac epicardium, as well as
aspects of the septum transversum, arises from lateral plate
mesoderm and is closely associated with the pre-hepatic endo-
derm. Several lines of evidence support the contention that the
septum transversum mesenchyme is required for early stages
of hepatic development, when the embryo has only generated
about 2–4 somites. GATA4, a zinc finger transcription factor, is
robustly expressed in septum transversum mesenchymal cells
that surround the liver bud. Examination ofGata4/ embryos re-
vealed that the septum transversum and proepicardial mesen-
chyme is absent in these embryos (Watt et al., 2004) and that
the liver bud fails to expand (Watt et al., 2007). GATA4 regulates
expression of the secreted bone morphogenetic protein, BMP4
(Nemer and Nemer, 2003), which, like GATA4, is highly ex-
pressed in the septum transversum mesenchymal cells at the
eight somite stage of mouse development (Rossi et al., 2001).
Analyses of Bmp4/ mouse embryos also revealed a delay in
expansion of the liver bud and addition of BMP inhibitors were
found to block hepatic specification in vitro (Rossi et al., 2001).
Although these data support a model whereby GATA4 controls
Table 1. Predominant Cell Types and Their Functions within the Adult Liver
Cell Type Position in Liver Function
Hepatocyte Parenchyma 70% of liver cell population
Protein secretion
Bile secretion
Cholesterol metabolism
Detoxification
Urea metabolism
Glucose/glycogen metabolism
Acute phase response
Blood clotting
Cholangiocyte/bile duct cell Duct epithelium 3% of liver cell population
Form bile ducts to transport bile
Control rate of bile flow
Secrete water and bicarbonate
Control pH of bile
Endothelial cell Vasculature Form veins, arteries, venuoles, and arterioles
Control blood flow
Contribute toward parenchymal zonation
Liver sinusoidal endothelial cell Sinusoids 2.5% of lobular parenchyma
Form sinusoidal plexus to facilitate blood circulation
Highly specialized
Allow transfer of molecules and proteins between serum and hepatocytes
Scavenger of macromolecular waste
Cytokine secretion
Antigen presentation
Blood clotting
Pit cell Liver natural killer cells Rare
Cytotoxic activity
Kupffer cell Sinusoids 2% of liver
Scavengers of foreign material
Secrete cytokines and proteases etc.
Hepatic stellate cell Perisinusoidal 1.4% of liver cells
Maintenance of extracellular matrix, Vitamin A, and retinoid storage
Controls microvascular tone
Activated to become myofibroblast
Contributes toward regenerative response to injury
Secretion of cytokines
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hepatic development, it is worth noting that both factors are ex-
pressed in other cell types in the immediate vicinity and, as is the
case for FGFs, several members of the BMP family are also
present, including BMP2. Nevertheless, the requirement for
both GATA4 and BMP4 in controlling early liver development is
conserved, since both are essential for hepatogenesis in zebra-
fish (Holtzinger and Evans, 2005; Shin et al., 2007).
Recent studies in mouse embryos have also highlighted the
highly dynamic nature of the signaling events that control hepatic
specification (Wandzioch and Zaret, 2009). Using a combination
of mouse embryo culture, conditional genetic ablation, and phar-
macological intervention, Zaret and colleagues provided
evidence to support a model whereby TGFb signaling acts to
restrict endoderm specification as cell movements position
progenitors within the appropriate inductive environments.
Moreover, the authors found that there is a measure of flexibility
on the relative timing of BMP and FGF signaling that induces
distinct populations of hepatic progenitors to differentiate. In
the proposed model, TGFb acts as a developmental timer toensure that the endoderm retains hepatic competency and is
prevented from inappropriately differentiating.
The WNT signaling pathway has also been implicated during
the onset of hepatic development, although in contrast to a clear
inductive role for FGF and BMP, the contribution of WNT
signaling appears to be complex. Studies in Xenopus have
shown that canonical WNT signaling makes different contribu-
tions depending on the developmental stage (McLin et al.,
2007). At early somite stages WNT signaling acts in the posterior
endoderm to repress expression of Hhex, an essential transcrip-
tional regulator of hepatic development. If canonical WNT
signaling is blocked in the posterior endoderm it results in
ectopic liver development. Repression of WNT signaling by
expression of WNT antagonists in the anterior endoderm is,
therefore, required to relieve repression of Hhex in the anterior
endoderm and so facilitate commitment of the endoderm to
a hepatic fate. In contrast to the repressive effects of WNTs at
early somite stages, following specification, WNT signaling
appears to promote hepatogenesis in multiple systems including
Xenopus (McLin et al., 2007) and zebrafish (Ober et al., 2006;Developmental Cell 18, February 16, 2010 ª2010 Elsevier Inc. 177
Figure 2. Mechanisms Controlling Early
Development of the Hepatic Parenchymal
Cells
Illustration showing the onset of differentiation of
liver parenchymal cells indicating signaling mole-
cules and transcription factors with proven regula-
tory roles. Early functions of Wnt signaling
promote posterior endodermal identity at the
expense of anterior (e.g., prospective hepatic)
identity, and must be inhibited anteriorly by local
Wnt antagonist expression before liver develop-
ment can proceed further. Later functions of Wnt
signaling act in parallel with BMP and FGF
signaling to drive hepatic specification, expansion,
and differentiation. Foregut endoderm (End; pink),
heart (He; red), liver bud (Lb; yellow), septum
transversum mesenchyme/lateral plate meso-
derm (STM; green), and vascular endothelial cells
(E; black).
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tified as a being essential for the onset of differentiation of the
hepatic progenitor cells. This factor is expressed in the lateral
plate mesoderm that is positioned adjacent to the endoderm
that is destined to become the fish liver. Interestingly, although
Wnt2bb mutants fail to initially specify hepatic progenitors,
most embryos recover to form normal livers and develop into
adult fish (Ober et al., 2006). This implies that additional mecha-
nisms exist that can compensate for Wnt2bb signaling in zebra-
fish. Whether the compensatory growth of the liver occurs
through a response of the original liver field or whether other
regions of the gut adopt a liver cell fate in response to loss of
Wnt2bb is an outstanding question.
Transcriptional Control of Hepatic Progenitor Cell
Differentiation
In addition to identifying signaling molecules, a substantial effort
has been devoted to describing the transcription factors that
control the initial stages of hepatic development (for reviews
see Zaret, 2008; Lemaigre, 2009; Hannenhalli and Kaestner,
2009). Although expressed at low levels, Albumin is one of the
best characterized markers of nascent hepatic cells (Cascio
and Zaret, 1991). DNA footprinting analyses of the transcriptional
regulatory elements controlling the onset of Albumin expression
during hepatic development revealed that FoxA and GATA4 both
of which are expressed in the anterior endoderm, were capable
of binding to the Albumin enhancer before the onset of Albumin
expression (Gualdi et al., 1996; Bossard and Zaret, 1998). Both
FoxA and GATA4 have the capacity to interact with their respec-
tive binding sites in the context of compacted chromatin (Cirillo
et al., 1998, 2002; Cirillo and Zaret, 1999) and the binding of
these factors results in displacement of linker histone H1 and
repositioning of nucleosomes. This has led to the model that
such transcription factors can act as ‘‘pioneer’’ factors to mark
domains of chromatin as competent to be expressed in res-
ponse to appropriate developmental cues (reviewed in Kaestner,
2005). Recent studies have shown that FoxA has an unusually
slow nuclear mobility which is consistent with high non-specific
nucleosome binding (Sekiya et al., 2009). It has been suggested
that the slow nuclear mobility of FoxA may facilitate its ability to
probe sites in nuclear DNA that are inaccessible to conventional
transcriptional activators due to the presence of chromatin,178 Developmental Cell 18, February 16, 2010 ª2010 Elsevier Inc.which would be consistent with FoxA acting as a pioneer factor.
Further support for this model also comes from the finding that
mice lacking both FoxA1 and FoxA2, which are functionally
redundant, fail to initiate development of the hepatic lineage
both in mice and in response to FGF treatment of cultured endo-
derm (Lee et al., 2005). Interestingly, hepatocyte differentiation
and control of gene expression, following specification of the
liver progenitors, appears to be independent of FoxA1/A2 (Li
et al., 2009).
Studies in mouse embryos have found that the homeodomain
transcription factor HNF1b is also essential for hepatic specifica-
tion (Lokmane et al., 2008). In embryos lacking HNF1b, the
mesenchymal portion of the liver forms relatively normally,
however, the liver bud fails to express any markers of hepatic
parenchymal cell progenitors and the level of mRNAs encoding
the FoxA factors was severely reduced. In addition, when
cultured in the presence of FGF, in contrast to control endoderm,
Hnf1b/ ventral endoderm failed to express albumin, which is
consistent with a crucial contribution of HNF1b in controlling
hepatic specification.
Between the 7 and 11 somite stages of development in the
mouse, around embryonic day (E)8.5, in response to the induc-
tive cues from the heart and mesenchyme, the cells forming
the hepatic endoderm that lie proximal to the sinus venosus tran-
sition to a columnar morphology (Bort et al., 2006) and express
several hepatic genes including Albumin, Afp, Ttr (transthyretin),
Rbp (retinol binding protein), and the transcription factor Hnf4a,
all of which are reliable indicators of early hepatic cell fate. The
transition in cellular morphology results in a thickening of the
epithelium, which bulges into the surrounding stroma. The basal
face of the diverticulum is surrounded by a matrix which contains
laminin, nidogen, type IV collagen, fibronectin, and heparin
sulfate proteoglycans (Shiojiri and Sugiyama, 2004). At around
21 somites in the mouse, nuclear migration within the epithelial
cells results in a pseudostratified epithelial morphology. The
matrix surrounding the basal surface of the epithelium is then
degraded and E-cadherin expression is downregulated in the
hepatic cells as they delaminate and invade the surrounding
stroma as migrating cords of hepatoblasts (Medlock and
Haar, 1983; Bort et al., 2006). The migration of the hepatic
progenitor cells into the stroma requires the action of matrix
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MMPs have been identified in the vicinity of the liver bud
including MMP-14 in the hepatic progenitors and MMP-2 in the
surrounding mesenchyme.
Analyses of mutant mouse embryos have identified several
transcription factors that control the formation and expansion
of the primary liver bud. The homeobox transcription factor
Hhex regulates proliferation and positioning of the ventral endo-
derm within the cardiogenic field that controls induction of
hepatic cell fate (Bort et al., 2004) and is required to ensure pseu-
dostratification. In the absence of Hhex, mutant mouse embryos
initiate hepatic specification (Bort et al., 2004) but fail to
complete liver bud morphogenesis, resulting in hepatic struc-
tures that lack a parenchymal cell component (Keng et al.,
2000; Martinez Barbera et al., 2000). Conditional ablation of
the Hhex gene in the early hepatoblasts also disrupts their differ-
entiation into hepatocytes (Hunter et al., 2007) suggesting that
Hhex has multiple roles in controlling the onset of hepatogene-
sis. In addition to the mesodermal functions discussed above,
GATA4 and/or GATA6 may also contribute more directly to hep-
atoblast development by transactivating the Hhex promoter
(Denson et al., 2000; Watt et al., 2007; Zhao et al., 2005).
However, further study is required to establish a cell autonomous
requirement.
A number of other transcriptional regulators have been char-
acterized as playing a role in later events. For example, the ho-
meodomain factors HNF6 (also called Onecut-1) and Onecut-2
are redundantly required for hepatoblast migration (Margagliotti
et al., 2007). The prospero-related homeobox transcription
factor Prox1 also promotes hepatoblast proliferation and migra-
tion from the primary liver bud (Sosa-Pineda et al., 2000).
Although the mechanism through which Prox1 controls hepato-
blast migration is unclear, the mutant hepatoblasts were found to
maintain high levels of E-cadherin and failed to degrade the
basal matrix surrounding the liver bud. Recent work has shown
that the T box transcriptional repressor Tbx3 may act upstream
of Prox1 (Lu¨dtke et al., 2009). Interestingly, the block in expan-
sion of the Tbx3/ liver bud is accompanied, not only by persis-
tence of epithelial adhesion and matrix characteristics as
discussed above in the context of Prox1/, but also by an
apparent change in the fate of the hepatoblasts. In control
embryos the expression of key regulators of hepatocyte differen-
tiation including Hnf4a and c/EBPa are strongly expressed in the
migrating hepatoblasts, whereas expression of transcription
factors that primarily control cholangiocyte fate, such as HNF6
and HNF1b, are found to be at very low levels. In Tbx3 mutant
mice expression of Hnf4a and c/EBPa is lost while levels of
HNF6 and HNF1b are increased suggesting that Tbx3 normally
promotes a hepatocyte fate and represses a cholangiocyte
fate. Moreover, the authors of this work promote the interesting
possibility that the inability of the cells to delaminate from the
hepatogenic endoderm is a secondary consequence of failure
of the endoderm to initiate differentiation toward the hepatocyte
lineage (Lu¨dtke et al., 2009). If this is true then the interpretation
of other mutations affecting liver bud expansion and hepatoblast
migration may have to be revisited. In summary, analyses of
mouse embryos harboring mutations in genes encoding several
transcription factors suggest that establishment of a network of
transcription factors during liver bud morphogenesis is essentialfor both commitment of the ventral endoderm to a hepatic fate as
well as for subsequent morphogenesis of the early liver bud and
that these processes are intricately intertwined.
Transcriptional Transitions during Differentiation
The hepatoblasts that migrate into the septum transversum
appear to have the potential to differentiate into either cholangio-
cytes or hepatocytes. Cells that follow a hepatocyte cell fate
progressively mature and, during the remainder of both embry-
onic and postnatal development, accumulate the gene expres-
sion and physiological profile of mature hepatic parenchymal
cells (Ge et al., 2005; Jochheim et al., 2003). The maturation of
hepatocytes is facilitated through an expanding and complex
network of transcription factors that regulate hepatocyte gene
expression. Detailed expression and chromatin immunoprecipi-
tation studies of 12 hepatic transcriptional regulators during hep-
atogenesis have revealed a dynamic and complex set of interac-
tions that are required to establish mature hepatocyte identity
(Kyrmizi et al., 2006). By comparing developmental time points,
the complexity of cross-regulation among factors was found to
gradually increase as development progressed and the number
of transcription factors binding a given promoter also became
greater. The increase in cross-regulation between liver transcrip-
tion factors during hepatogenesis is likely to stabilize the regula-
tory circuitry to ensure terminal differentiation of the hepatocytes
as development progresses. Six transcription factors, (HNF1a,
HNF1b, FoxA2, HNF4a1, HNF6, and LRH-1 [Nr5a2]), were found
to form the core of this regulatory circuitry by occupying each
others promoters as well as the promoters of peripheral hepatic
transcription factors.
As discussed above, gene deletion studies in mouse embryos
have found that HNF1b, FoxA2, and HNF6 all have roles in
controlling the onset of hepatic gene expression during specifi-
cation and liver bud formation, which is consistent with these
factors having important roles in establishing the transcription
factor network within the liver progenitor cells. Mice lacking
HNF1a complete embryogenesis with little impact upon liver
development (Pontoglio et al., 1996), which likely reflects the
observation that HNF1b occupies most HNF1-binding sites
during development. As development progresses, however,
promoter sequences that are occupied by HNF1b in fetal hepa-
tocytes are found to be bound by HNF1a in the adult. Loss of
HNF4a does not have an impact on hepatic specification;
however, subsequent differentiation of the hepatic progenitors
is blocked (Li et al., 2000; Parviz et al., 2003). When HNF4a is
specifically removed from fetal hepatoblasts, hepatic architec-
ture is also severely affected, with livers exhibiting loss of
endothelial cells and disrupted hepatocellular polarity. The loss
of hepatocyte polarity in Hnf4a/ livers appears to reflect
a requirement for HNF4a in controlling expression of several
proteins involved in cell junction assembly (Battle et al., 2006).
Moreover, in the absence of HNF4a the core regulatory net-
work is severely disrupted in fetal hepatic progenitors
(Kyrmizi et al., 2006); however, in adult hepatocytes, mainte-
nance of the transcription factor network appears to be less
dependent on HNF4a, although HNF4a does continue to have
an important role in maintaining adult hepatocyte function (Hay-
hurst et al., 2001). The importance of HNF4a in maintaining
mature hepatocyte character in adult livers is also supportedDevelopmental Cell 18, February 16, 2010 ª2010 Elsevier Inc. 179
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occupy 12% of genes in human hepatocytes (Odom et al., 2004).
Maturation of Hepatocytes within the Liver Parenchyma
Several reviews have covered the role of transcription factors in
regulating gene expression in mature hepatocytes (Friedman
and Kaestner, 2006; Spear et al., 2006; Lemaigre, 2009). The
networks of transcriptional activators and cofactors that control
the liver’s metabolic and cellular functions are extremely diverse
relying on members of all known transcription factor families. In
addition to the expression of hepatic genes throughout the
parenchyma, expression of some genes is restricted to zonal
regions that are often related to the position of the portal triad
(periportal) or central veins (pericentral/perivenous; Jungermann
and Katz, 1989). Heterogeneous expression can be described as
either forming a gradient, where expression is gradually dimin-
ished across hepatocytes within a zone, or compartmentalized,
where strict boundaries of expression within hepatocytes is
observed (Spear et al., 2006). From a functional perspective
the zonation of the liver lobules has been studied intensely (re-
viewed by Kaestner, 2009). However until recently, surprisingly
little was known about the molecular mechanisms controlling
zonal gene expression (Burke and Tosh, 2006).
Recent studies have highlighted an important contribution of
the WNT/b-catenin signaling pathway in controlling the posi-
tional identity of hepatocytes within the liver lobule (Kaestner,
2009). Work in mice revealed that b-catenin is important for zonal
gene expression in perivenous hepatocytes and this activity is
antagonized by adenomatous polyposis coli (APC) in the peri-
portal regions (Benhamouche et al., 2006; Burke et al., 2009).
Analyses using mice in which a transgene is expressed from
a regulatory element from within the alphafetoprotein enhancer
have suggested that compartmentalized zonal expression may
be due to the action of a transcriptional repressor (Peyton
et al., 2000). Moreover, examination of mice that lack HNF4a
specifically in hepatocytes found an increase in periportal
expression of a subset of perivenous expressed genes including
glutamine synthetase (Stanulovic´ et al., 2007). Although oligonu-
cleotide array analyses are consistent with HNF4a acting
predominantly as a transcriptional activator (Battle et al., 2006),
HNF4a was found to directly interact with the glutamine synthe-
tase enhancer suggesting that HNF4a inhibits expression of peri-
central mRNAs in periportal hepatocytes possibly by recruiting
the histone deacetylase protein HDAC1 (Stanulovic´ et al.,
2007). More recently a direct link between the repressive activity
of HNF4a and b-catenin signaling has been established (Colletti
et al., 2009). Activation of the Wnt pathway converted hepato-
cytes that exhibited a periportal character to those that ex-
pressed perivenous markers. In response to activation of Wnt
signaling, a transcription factor activated by b-catenin called
LEF1 was found to physically interact with HNF4a. In perivenous
gene promoters, including that of glutamine synthetase, binding
of both HNF4a and LEF1 was required for gene activation and
when HNF4a alone was bound expression was repressed. In
contrast, periportal gene promoters could be activated by
binding of HNF4a alone and ectopic activation of LEF1 inhibited
gene expression. Why HNF4a fails to activate expression of the
perivenous promoters and instead act as a repressor remains to
be determined as does the nature of the Wnt pathway agonists180 Developmental Cell 18, February 16, 2010 ª2010 Elsevier Inc.whose activity presumably defines the perivenous expression
profile (Kaestner, 2009).
In addition to the heterogeneous expression of subsets of
genes throughout different parenchymal zones, expression of
several genes, including alphafetoprotein, H19, and Glypican-3
(Spear et al., 2006), is robust in fetal hepatocytes and sharply
reduced in fully differentiated cells. This switch in expression
from a fetal to adult expression program is of biomedical interest
because it is often reversed as hepatic cells become cancerous.
How such differential regulation is controlled has been studied
for over three decades. Recent studies of the alphafetoprotein
promoter have revealed an important role of transcriptional
repressors in controlling the transition of the gene expression
profile within hepatocytes from fetal to an adult. Alphafetoprotein
regulator 1 (Afr) was genetically defined as a locus that conferred
a high level of AFP expression in the livers of adult Balb/cJ mice.
Recently, genetic mapping studies revealed that the increase in
AFP expression in adult livers was a consequence of a retrovirus
insertion into the Zhx2 gene (Perincheri et al., 2005). Although all
data support an important role for Zhx2 in mediating repression
of Afp expression, a direct interaction with the Afp promoter has
not been identified, raising the possibility that Zhx2 regulates Afp
indirectly. Further studies have shown that the negative regula-
tion mediated by Zhx2 is not restricted to the Afp gene, since
Zhx2 also represses expression of H19 and glypican-3 (Morford
et al., 2007; Perincheri et al., 2005). In addition to Zhx2, hepato-
cyte specific deletion of the zinc finger protein ZBTB20 resulted
in a dramatic increase in expression of AFP in adult hepatocytes
(Xie et al., 2008). Molecular analyses found that ZBTB20 could
directly bind the Afp promoter and was able to repress expres-
sion mediated by this promoter. While both of these factors
clearly have important roles in defining the gene expression
profile of fully differentiated hepatocytes any relationship
between the two factors is yet to be determined.
The Hepatic Vasculature and Stromal Compartment
Development of the Large Blood Vessels
Following specification, hepatic progenitors interact with stromal
cells and several studies have shown that the stromal compart-
ment of the liver has important roles in controlling diverse
aspects of hepatic development. In the adult liver, the stromal
cell population primarily includes hepatic sinusoidal endothelial
cells, hepatic stellate cells, and Kupffer cells (KC). At E9.5 in
the mouse, before formation of functional blood vessels, endo-
thelial cells have been found to promote the outgrowth of the
hepatic progenitors from the liver bud (Matsumoto et al., 2001).
The acquisition of the hepatic vasculature advances through-
out embryogenesis, relying on both angiogenesis and vasculo-
genesis to generate the complex hepatic vascular network that
underlies liver function (Gouysse et al., 2002). The fetal liver is
in contact with two major venous systems, the umbilical veins
and the vitelline veins. The vitelline veins participate in the forma-
tion of the efferent venous system of the liver. The umbilical vein
is the major afferent vessel in the fetal liver, but its presence is
transient and it disappears after birth. When the umbilical vein
collapses, the portal vein replaces it as the major afferent vein
(for review, see Collardeau-Frachon and Scoazec, 2008).
Hepatic artery development occurs later than venous develop-
ment. It starts to form along the intrahepatic portal vein within
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(Gouysse et al., 2002). The current model suggests that intrahe-
patic arterial development in humans is driven by the ductal
plate that forms at the same stage and is a source of VEGF. In
mice, the same model is likely to apply with the exception that
arteries form near well-developed ducts instead of in the vicinity
of the less mature ductal plate (Clotman et al., 2003; Coffinier
et al., 2002).
Development of the Hepatic Sinusoidal Capillaries
Sinusoids, the smallest blood vessels of the liver, form a complex
three-dimensional plexus through which blood is transported
throughout the liver lobules. The sinusoids consist of hepatic
sinusoidal endothelial cells and stellate cells. Sinusoidal endo-
thelial cells are highly specialized, having important roles in the
transfer of solutes between serum and hepatocytes as well as
the clearance of soluble macromolecules (Elvevold et al.,
2008). They have a number of specialized features including
the presence of multiple fenestrations that are arranged as clus-
ters called sieve-plates that may facilitate transfer of factors
between the sinusoidal lumen and the surface of the hepato-
cytes (Figure 1C; Wisse, 1972). Sinusoidal endothelial cells share
some similarities to lymphatic endothelial cells including the
expression of the lymphatic vascular endothelial hyaluronan
receptor-1 (LYVE-1) (Mouta Carreira et al., 2001). Furthermore,
sinusoidal endothelial cells were shown to express VAP1, Stabi-
lin 1 and 2, L-SIGN, and Reelin, have a low expression of PECAM
(CD31) and von Willebrand factor, and do not express the type 1
transmembrane sialomucin (CD34), which is typically found in
classical endothelial cells (Lalor et al., 2006; Nonaka et al., 2007).
Sinusoids are the first blood vessels to form during hepato-
genesis, where they develop by angiogenesis from existing
vessels in the septum transversum mesenchyme (Collardeau-
Frachon and Scoazec, 2008; Couvelard et al., 1996; Enzan
et al., 1983). As development progresses, the sinusoidal endo-
thelial cells gradually adopt the functional and structural charac-
teristics of mature sinusoids and this correlates with changes in
expression of extracellular matrix components that may influ-
ence the maturation process (Couvelard et al., 1996, 1998; Non-
aka et al., 2007). Although angiogenesis appears to be the
primary mechanism through which the sinusoids are formed,
some studies have suggested that the growth of the sinusoids
during embryogenesis, at least in the case of avian embryos,
may be partially facilitated by the introduction of endothelial cells
that originate from mesothelial precursors, (Pe´rez-Pomares
et al., 2004). Although the molecular mechanisms that control
growth and maturation of sinusoidal endothelial cells are not
well defined, several studies support a role for Wnt signaling in
their proliferation and differentiation (Klein et al., 2008; Matsu-
moto et al., 2008; Zeng et al., 2007). In particular, Wnt2 was
shown to be expressed in rat hepatic sinusoidal endothelial cells
and could increase their proliferation through activation of
canonical b-catenin signaling (Klein et al., 2008). Moreover,
when Wnt2 levels were depleted it resulted in a decrease in
expression of VEGF receptor 2 in rat sinusoidal endothelial cells.
This implies that the autocrine activity of Wnt2 cooperates with
VEGF signaling to control sinusoidal endothelial cell growth in
the liver. The sinusoidal endothelial cells can also impact prolif-
eration of the hepatocytes (LeCouter et al., 2003). Treatment of
mice with VEGF-A results in an increase in liver parenchymalcell proliferation and liver mass. Studies using primary hepato-
cyte-sinusoidal cell cocultures revealed that this increase in
hepatocyte proliferation was due to the secretion of a number
of mitogenic factors, including HGF and IL6, from the sinusoidal
endothelial cells in response to activation of the VEGF receptor.
Developmental Interactions of the Liver with the Fetal
Hematopoietic Environment
In mammals soon after the liver progenitors invade the
surrounding mesenchyme, the fetal liver is colonized by hemato-
poietic progenitors and transiently becomes the principal hema-
topoietic organ. Coculture studies have suggested that imma-
ture hepatic progenitor cells can generate an environment that
supports hematopoiesis (Hata et al., 1993); however, when
hepatic progenitor cells are induced to differentiate to a mature
form, the resulting cells can no longer support blood cell devel-
opment (Kinoshita et al., 1999), consistent with the movement
of hematopoietic stem cells from the fetal liver to the adult
bone marrow, during this general timeframe. In addition to the
parenchymal cells, fetal liver-derived stromal cells have been
shown to enhance hematopoietic progenitor cell proliferation
possibly through Wnt signaling pathways (Martin and Bhatia,
2005). Conversely, hematopoietic cells within the fetal liver
express the cytokine Oncostatin M (OSM) (Yoshimura et al.,
1996). Addition of Oncostatin M to liver progenitor cells in culture
was found to enhance their differentiation into hepatocytes and
loss of the gp130 subunit of the Oncostatin M receptor had
a negative impact on hepatocyte differentiation in mice (Kamiya
et al., 1999). Together, these studies suggest that there exists
a dynamic interplay between the blood and parenchymal
compartments within the fetal liver that controls the timing of
both hepatogenesis and hematopoiesis.
Stellate and Kupffer Cells during Hepatogenesis
Hepatic stellate cells reside in the perisinusoidal space (space of
Disse) between the basolateral surface of the hepatocytes and
abluminal surface of the sinusoidal endothelial cells. Recent
studies have revealed that the cells have many important activ-
ities that impact liver function and development (Friedman,
2008). The better characterized roles include the ability of stellate
cells to store vitamin A and to modulate hepatic microcirculation
in response to endothelin signaling (Housset et al., 1993; Wata-
nabe et al., 2007). After hepatic lesion or under pathological
conditions, hepatic stellate cells can also become activated to
adopt a myofibroblast character and chronic activation of stel-
late cells leads to liver fibrosis (for review see Friedman, 2008).
The origin of hepatic stellate cells has been debated, with various
lines of evidence suggesting that the cells are of endodermal,
neural crest, or mesenchymal origin. Most of the conclusions
drawn from such studies were based on expression of shared
sets of marker genes; however, shared gene expression does
not necessarily correlate with cell lineage. Direct lineage tracing
experiments have been performed in avian embryos (Pe´rez-Po-
mares et al., 2004), which led to the conclusion that mesothelial
cells derived from the proepicardium and septum transversum
mesenchyme could give rise to both endothelial and stellate cells
within the hepatic sinusoids. Recent studies in human (Loo and
Wu, 2008) and in mouse (Asahina et al., 2009) support a mesothe-
lial origin of hepatic stellate cells. Submesothelial cells express
activated leukocyte cell adhesion molecule (ALCAM) and after
FACS sorting, ALCAM-positive cells were found to acquireDevelopmental Cell 18, February 16, 2010 ª2010 Elsevier Inc. 181
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forming lipid droplets when cultured in a three-dimension
collagen gel in the presence of retinol, a feature that is character-
istic of quiescent hepatic stellate cells (Asahina et al., 2009).
Whether mesothelial cells are the sole source of hepatic stellate
cells or whether they can differentiate from other fetal lineages
will require further lineage tracing experiments.
Gene knockout studies in mice have suggested that hepatic
stellate cells and derivatives of the septum transversum mesen-
chyme may contribute toward the fate of other hepatic cell line-
ages. The homeobox protein Hlx is expressed in the septum
transversum and visceral mesenchyme but is not detected in
the endoderm or its derivatives. Examination of Hlx/ mouse
embryos found that at E12.5 the livers were severely hypoplastic
containing only 3% of the cells found in control livers (Hentsch
et al., 1996). Although at E9.5 the mutant livers appeared to
form hepatic cords and parenchymal cell lineages were speci-
fied and had initiated a differentiation program, the parenchymal
progenitors failed to proliferate. Whether this is due to regulation
of expression of mitogens or growth factors by Hlx remains to be
determined. Wilm’s Tumor (Wt1) and retinoic acid signaling are
involved in hepatic stellate cell development and liver morpho-
genesis (Ijpenberg et al., 2007). Analyses of Wt1 null fetal livers
revealed that that the absence Wt1 led to a decrease in expres-
sion of the retinoic acid synthesizing enzyme RALDH2 in hepatic
stellate cell progenitors. This in turn affected retinoic acid-medi-
ated liver growth resulting in liver hypoplasia and abnormal liver
lobe formation (Ijpenberg et al., 2007; Sucov et al., 1994). The
LIM homeobox gene Lhx2 is also expressed in the septum trans-
versum mesenchyme and stellate cells throughout liver develop-
ment (Kolterud et al., 2004). Loss of Lhx2 in mice resulted in
abnormal stellate activation and mice developed hepatic
fibrosis, which is consistent with the proposal that Lhx2 is re-
quired to maintain stellate cells in a quiescent state. Moreover,
examination of fetal Lhx2/ livers found an increase in deposi-
tion of extracellular matrix proteins, which appeared to result in
disorganization of the parenchyma, including increased expres-
sion of hepatocyte genes and disrupted architecture of the sinu-
soidal trabeculae.
Kupffer cells are resident macrophages on the surface of
hepatic sinusoidal endothelial cells. They represent 15% of the
liver cell population and 50% of resident macrophages in the
body. There is no clear report on the role of Kupffer cells in liver
organogenesis. However, some data suggest that Kupffer cells
or their progenitors may be involved in maturation of erythro-
cytes during fetal liver hematopoiesis (for review, see Naito
et al., 2004). In addition to a possible contribution to erythyropoi-
esis, selective depletion of Kupffer cells using liposome-encap-
suled dichloromethylene diphosphonate (Cl2MDP) in adult
mice or rats after partial hepatectomy (PH) lead to a delay in
hepatic regeneration (Meijer et al., 2000). In the absence of
Kupffer cells, there is a decrease in the levels of secreted
TNF-a and IL-6 compared to normal liver and the delay in liver
regeneration was attributed to a lack of NF-kB activation
(Abshagen et al., 2007).
Development of the Biliary Tree
A major function of the liver is to generate bile that is transported
to the intestine where it is required for the emulsification of fat.182 Developmental Cell 18, February 16, 2010 ª2010 Elsevier Inc.These secretions are released from the apical surface of the
hepatocytes and are transported through a network of intrahe-
patic ducts into the extrahepatic biliary tract which consists of
the hepatic and cystic ducts, the gallbladder, and the common
bile duct.
Development of the Extrahepatic Biliary Tract
The extrahepatic biliary tract originates from a portion of the
ventral endoderm that is positioned immediately rostral to the
ventral pancreatic bud. A recent report demonstrated that
the extrahepatic biliary tract derives from pancreatobiliary
precursors coexpressing PDX1 and SOX17 (Spence et al.,
2009). This precursor population gives rise to SOX17+/PDX1
extrahepatic biliary cells and SOX17/PDX1+ pancreatic cells.
The segregation of the pancreatobiliary precursor population
depends on SOX17. This factor is required for extrahepatic
biliary tract development and overexpression inhibits pancreas
development. The expression of SOX17 is controlled by
homolog of hairy/enhancer-of-split (Hes-1): in the absence of
Hes-1 the mice not only display accelerated differentiation of
pancreatic endocrine cells from pancreatic progenitors (Jensen
et al., 2000), the bile duct cells also differentiate to a pancreatic
phenotype (Fukuda et al., 2006; Sumazaki et al., 2004). Other
transcription factors involved in extrahepatic biliary development
include Hhex: in Hhex null embryos the common bile duct is
replaced by duodenal-like tissue suggesting that the decision
between a dudodenal or biliary fate appears to depend, at least
in part, on the function of this transcription factor (Hunter et al.,
2007). Mice deficient in HNF6, Hes-1, HNF1b, or FoxF1 show
lack or abnormal shape of the gallbladder (Clotman et al.,
2002; Sumazaki et al., 2004; Coffinier et al., 2002; Kalinichenko
et al., 2002).
Cell Signals Controlling Development of Intrahepatic
Bile Ducts
While the extrahepatic cholangiocytes derive directly from the
endoderm, the cholangiocytes that line the intrahepatic bile
ducts arise from hepatoblasts. The earliest sign of biliary differ-
entiation is expression of Sox9, a transcription factor that
controls the timing of bile duct development (Antoniou et al.,
2009). Sox9-positive cells are first found close to the branches
of the portal vein where they form the ductal plate (Figures 3B
and 3C). The ductal plate is a continuous ring of cells arranged
as a monolayer that surrounds the periportal mesenchyme.
Two signaling mechanisms have emerged as key determinants
of localized biliary differentiation. Transforming growth factor-
beta (TGF-b) ligands generate a gradient of TGF-b signaling
with high activity near the vein and lower activity in the paren-
chyma (Antoniou et al., 2009; Clotman et al., 2005). The appro-
priate concentration of TGF-b is required to induce differentia-
tion of biliary cells from periportal hepatoblasts. When TGF-b
signaling in the parenchyma is excessive, a biliary differentiation
program is superimposed upon the hepatocytes leading to the
development of hybrid hepato-biliary cells (Clotman et al.,
2005). The Notch signaling pathway was also suspected of
contributing to biliary development based on the finding that
patients affected with Alagille syndrome, a polymalformative
disease with bile duct paucity, had mutations in the JAGGED1
and NOTCH2 genes (Li et al., 1997; Oda et al., 1997; McDaniell
et al., 2006). The analysis of this pathway in the liver has been
challenging due to the presence of multiple ligands and
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Figure 3. Development of the Bile Ducts
(A) Gene network regulating bile duct develop-
ment.
(B and C) Bile duct morphogenesis progresses
from the hilum of the liver to the periphery of the
lobes. The biliary tree is schematically represented
at a stage when ducts have reached maturity near
the hilum (section 4), while peripheral structures
still show cholangiocytes forming a single-layered
ring of cells (ductal plate; section 1). Two interme-
diate maturation stages illustrate the progression
from asymmetrical to radially symmetrical ducts,
as well as markers that characterize the hepato-
blasts and cholangiocytes that line the developing
ducts are mentioned (sections 2 and 3). When
morphogenesis progresses, the ductal plate areas
are not involved in duct formation regress.
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2008). However, recent data favor a model in which Notch
signaling controls multiple steps in biliary development,
including the initial differentiation of cholangiocytes. Analysis of
mice that have a liver-specific inactivation of RBP-Jk, a common
transcriptional mediator of Notch signaling, revealed a reduced
number of biliary cells differentiating from hepatoblasts (Zong
et al., 2009). Since expression of Jagged1 occurs in the peripor-
tal mesenchyme and biliary cells while Notch2 is present in the
biliary cells(Zong et al., 2009; Geisler et al., 2008), it appears
that Notch signaling contributes not only to differentiation of
biliary cells but also restricts differentiation to a periportal loca-
tion. Other signals, including Wnt (Hussain et al., 2004; Monga
et al., 2003; Tan et al., 2008; Decaens et al., 2008), FGF, and
BMP (Yanai et al., 2008), also regulate the differentiation of hep-
atoblasts to cholangiocytes; however, in contrast to TGF-b andDevelopmental Cell 18,Notch their role in restricting biliary differ-
entiation to the periportal area is less
clear.
Transcriptional Control of
Intrahepatic Bile Duct Development
and Duct Remodeling
Transcriptional regulation of biliary differ-
entiation has also been a focus of intense
research (Figure 3A), with most data
collected from the analyses of transcrip-
tion factor-deficient mice. Such animals
commonly retained hepatic cells that ex-
hibited characteristics of both hepato-
cytes and cholangiocytes, as was the
case in animals lacking Hhex, HNF6, One-
cut-2, or C/EBPa (Hunter et al., 2007;
Clotman et al., 2005; Yamasaki et al.,
2006). In the case of mice lacking both
HNF6 (OC-1) and Onecut-2 (OC-2), which
act redundantly, the phenotype was ex-
plained by repression exerted by the
factors on TGF-b signaling. When both
HNF6 and Onecut-2 were absent, TGF-b
signaling was enhanced resulting in an
expansion of the signaling gradient (Clot-
man et al., 2005). Other transcriptionfactors act to control cholangiocyte differentiation in a cell-
autonomous manner by controlling biliary cell gene expression.
For example, FoxM1B and Sall4 drive biliary differentiation, while
Tbx3 represses the process (Oikawa et al., 2009; Krupczak-
Hollis et al., 2004; Lu¨dtke et al., 2009; Suzuki et al., 2008). In
addition, recent studies revealed that when both FoxA1 and
FoxA2 were deleted in the developing hepatoblasts, the mutant
mice developed hyperplasia of the biliary tree as a consequence
of excessive cholangiocyte proliferation (Li et al., 2009). This ap-
peared to result from perturbed expression of IL-6, which can
induce cholangiocyte proliferation: in the absence of FoxA1/12
the glucocorticoid receptor, an inhibitor of IL6 gene transcrip-
tion, no longer binds to the IL-6 promoter leading to increased
and prolonged expression of IL6. This implies that FoxA1/A2
have an important role in terminating bile duct expansion during
development.February 16, 2010 ª2010 Elsevier Inc. 183
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modeling that leads to the formation of bile ducts (Figures 3A–
3C). The ductal plate initially consists of a primary layer of polar-
ized cholangiocytes, then at specific locations a second layer
forms that is separated from the primary layer by a luminal
space. This second layer was recently shown to consist of hep-
atoblasts, thereby creating asymmetrical ductal structures, with
the portal side of the lumen delineated by cholangiocytes and the
parenchymal side by hepatoblasts (Antoniou et al., 2009). This
asymmetric cellular arrangement is transient as the hepatoblasts
on the parenchymal side of the primitive ducts differentiate to
form cholangiocytes, thereby producing ducts entirely lined by
cholangiocytes. The Notch pathway is instrumental in biliary
tubulogenesis. In the absence of the Notch effector Hes-1,
ductal structures failed to form (Kodama et al., 2004) and
stage-specific inactivation of the Notch pathway impaired duct
formation beyond the formation of a monolayered ductal plate
(Zong et al., 2009). The TGF-b receptor type II (TbRII) is ex-
pressed in the ductal plate monolayer and then becomes
repressed when the cholangiocytes mature during duct forma-
tion suggesting that TGF-b signaling may also contribute to
duct formation (Antoniou et al., 2009).
Several of the hepatic transcription factors (HNF6, Onecut-2,
HNF1b, C/EBPa, Hhex) required for differentiation of cholangio-
cytes (Clotman et al., 2002, 2005; Coffinier et al., 2002; Yamasaki
et al., 2006; Hunter et al., 2007) are also required for tubulogen-
esis of the ducts. However, whether the abnormal duct formation
in mouse embryos lacking these transcription factors result from
deficient differentiation or from abnormal morphogenesis is
unclear. Nevertheless, a tentative gene regulatory cascade can
be proposed, based on the expression of the factors in the
various mouse mutants (Figure 3A). Target genes directly regu-
lated by cholangiocyte transcription factors have in most cases
not yet been described. Candidates are genes that modulate
Activin/TGF-b signaling, such as Follistatin, TbRII, and
a2-macroglobulin, as well as the vesicular membrane fusion
protein vps33b, known to be required for duct development in
both humans and zebrafish (Matthews et al., 2005; Gissen
et al., 2004). These factors all require HNF6 and HNF1b for
normal expression (Matthews et al., 2005; Clotman et al., 2005).
Proliferation of cholangiocytes facilitates growth of the ducts
and starts at the end of gestation, when differentiation is termi-
nated and symmetrical ducts are formed. Polycystic diseases
affecting the liver are characterized by abnormal cholangiocyte
proliferation and often result from mutations in genes regulating
primary cilia function (Masyuk et al., 2009; Adams et al., 2008).
Primary cilia in cholangiocytes function as osmo-, mechano-,
and chemosensors and exert a tight control on cholangiocyte
proliferation (Masyuk et al., 2008). In the pancreas and kidneys,
ciliopathic genes are controlled by HNF6 and HNF1b (HNF6:
Cys1 and Pkhd1; HNF1b: Ift88/Tg737/Polaris, Pkd2, and
Pkhd1), indicating that they may be similarly targeted by HNF6
and HNF1b during duct development (Pierreux et al., 2006;
Gresh et al., 2004).
Finally, while most efforts have been devoted to the identifica-
tion of signaling pathways and transcription factors regulating
biliary development, recent evidence points to important
posttranscriptional control exerted by a host of microRNAs.
miR-30a and miR-30c are expressed in developing ducts and184 Developmental Cell 18, February 16, 2010 ª2010 Elsevier Inc.their inhibition in zebrafish results in abnormal duct development
(Hand et al., 2009a). Interestingly, mRNAs targeted by the
miR-30a and miR-30c miRNAs include those encoding ActivinA
and epidermal growth factor receptor. Along the same lines,
miR-15a was found to repress proliferation of cholangiocytes
by inhibiting the expression of cdc25a (Lee et al., 2008). More-
over, the levels of miR15a were decreased in livers isolated
from the PCK rat, a model of autosomal recessive polycystic
kidney disease, as well as in patients with polycystic liver
disease. Although these data imply that repression of miR15a
may contribute to hepatic cystogenesis, studies in which Dicer,
which is essential for production of all miRNAs, was specifically
deleted in hepatocytes revealed that liver function was surpris-
ingly unaffected, although liver mass and hepatocyte prolifera-
tion were modestly increased (Hand et al., 2009b). Further,
studies in which specific miRNAs are depleted in the liver will
be neccessary before the role of miRNAs in controlling liver
development and hepatic function can be deciphered.
Conclusion
Through the rapid evolution of molecular genetic technologies
and the growth in the study of several new animal models our
understanding of the molecular mechanisms controlling liver
development has also become advanced compared to many
other organ systems. Several findings first found in the context
of liver development are generally applicable to the development
of other tissues and organs. For example, communication
between the vasculature and the endoderm as an essential
signaling event that governs hepatic cell fate has been found
to be reproduced in other organ systems including the pancreas
(Zaret, 2008). While such advances are exciting, it is clear that we
do not have a complete picture. We still do not understand the
mechanisms that regulate organ size, and our knowledge of
how individual tissue compartments interact to control cell matu-
ration, although improving, remains vague. Moreover, we still
have only a rudimentary understanding of why adult primary
hepatocytes rapidly dedifferentiate when placed in culture. As
more pathways and factors that regulate liver development are
revealed, it is likely that such questions will be answered.
The information gleaned from developmental studies, even at
its current level, has now been successfully applied to control the
differentiation of hepatocytes from stem cells. This has opened
up the possibility of using stem cell approaches in both the study
and possible treatment of liver disease. The feasibility of using
stem cells as a source of hepatocytes is also supported by
studies in both animal models (Grompe, 2006) and humans using
primary hepatocytes isolated from cadavers (Fisher and Strom,
2006). Recent work has shown that up to 90% of the mouse
hepatic parenchyma can be replaced with human hepatocytes
when such cells are transferred into immunocompromised fu-
marylacetoacetate hydrolase (Fah)-deficient animals (Azuma
et al., 2007; Bissig et al., 2007). When combined with the ability
to generate hepatocytes from either adult or embryonic stem
cells, this opens the possibility of using humanized mouse livers
to study and treat inborn errors of hepatic metabolism. Several
candidate diseases that could benefit from such approaches
have been described (Fisher and Strom, 2006; Grompe, 2006)
including urea cycle disorders, Wilson disease, Crigler-Najjar
syndrome type I, hyperlipidaemia, glycogen storage diseases,
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hypercholesterolemia, and tyrosinaemia type I.
Not only could the availability of an indefatigueable source of
primary hepatocytes facilitate the study of liver pathologies, it
could potentially allow the generation of bioartificial liver devices
(Strain and Neuberger, 2002). At the moment liver transplanta-
tion is successful in the treatment of liver disease; however,
the availability of donor organs is extremely limiting. If a device
could be established that could temporarily maintain basic liver
functions, it could act as a bridge until the patient’s own liver
completed a regenerative response or until a transplant was
available. Although the use of xenogeneic cells or cultured
hepatic cell lines in bioartifical liver devices have been described,
success has been limited by the need for large numbers of highly
differentiated human hepatocytes. However, building on basic
information gleaned from developmental studies, microscale
culture of highly differentiated primary human hepatocytes has
been described (Khetani and Bhatia, 2008). Moreover, three-
dimensional culture techniques have now been established
that support hepatocytes in a highly differentiated state that
could potentially be used as disease models and to study drug
toxicity and function (Sivaraman et al., 2005).
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